§ Federal grant opportunity · RFA-AR-28-001
NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed). The deadline is March 1, 2029 and the published award range is $500K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- March 1, 2029
- Award range
- $500K
- Eligibility
- small businesses, for profit organizations other than small businesses, other, private institutions of higher education, independent school districts, state governments, federally recognized native american tribal governments, public and indian housing authorities, city or township governments, nonprofits non higher education without 501c3, other native american tribal organizations, public and state institutions of higher education, special district governments, county governments, nonprofits non higher education with 501c3
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-AR-28-001
Program overview
The overall goal of this program is to accelerate scientific discovery, improve research efficiency, and enhance the translation of research findings into improved health outcomes. Centers funded under this program will also foster multidisciplinary collaboration, support workforce development across career stages, and promote training in emerging areas such as data science, artificial intelligence, and implementation research. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS P30 Centers Program to support integrated research Centers within its mission areas of skin biology and diseases; bone, muscle, and orthopaedic research; and rheumatic diseases. The NIAMS P30 Centers Program supports Centers that provide coordinated research infrastructure, shared resources, and methodological expertise to advance basic, translational, and clinical research. These Centers are expected to integrate state-of-the-art research resources with capabilities that support clinical and translational research, including the development, testing, and dissemination of novel analytical methods, study designs, outcome measures, and data-driven approaches.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before March 1, 2029, allowing time for registration and validation.
Related grant opportunities
- Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
- F24AS00298 Cooperative Agriculture
- NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.